ArticleClinical pharmacology and therapeutics2019

Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year.

Jonas Müntze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.